Abstract
Purpose The aim of this study was to evaluate the corneal thickness changes in the uncontrolled diabetics when proper control was achieved. Design This is a retrospective, randomized, clinical trial. Patients and methods The charts of 198 eyes of 99 uncontrolled diabetic patients (with glycosylated hemoglobin≥7%) were selected using standard random tables. Complete ophthalmologic examination with central corneal thickness (CCT) measurement using the Nidek tonoref III was extrapolated. The glycemic status of the patients was controlled (glycosylated hemoglobin <7%) in a 3-month period. The CCT of all patients was recorded before and after the glycemic control and was compared. Results The mean CCT value of the uncontrolled diabetic patients’ eyes was 531.38±35.56 μm (range=465–602 μm). After achieving the glycemic control, the mean CCT value was 533.95±32.33 μm (range=478–626 μm), with no statistically significant difference (t=−0.524, P=0.601). Conclusion The CCT values did not show any significant change in type-II diabetics after their transit from the uncontrolled to the controlled states.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
